CliffBio
small molecule

ELIGARD KIT

LEUPROLIDE ACETATE

Loss of exclusivityDecember 2041latest FDA-listed patent expiry
CompanyTolmar →See this company's full patent-cliff portfolio

Drug detail

Brand nameELIGARD KIT
Active ingredientLEUPROLIDE ACETATE
Strength22.5MG
Dosage formPOWDER
RouteSUBCUTANEOUS
ModalitySmall molecule
FDA approvalJuly 2002
Marketing statusRX

Listed patents

PatentExpiresType
12397120December 2041use U-4001
11931559December 2041substance
11771841December 2041substance, product

More from Tolmar

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ELIGARD KIT patent cliff — loss of exclusivity December 2041 | CliffBio